Bempegaldesleukin Plus Nivolumab in Untreated Advanced Melanoma: The Open-Label, Phase III PIVOT IO 001 Trial Results
Diab, Adi, Gogas, Helen, Sandhu, Shahneen, Long, Georgina V, Ascierto, Paolo A, Larkin, James, Sznol, Mario, Franke, Fabio, Ciuleanu, Tudor E, Pereira, Caio, Muñoz Couselo, Eva, Bronzon Damian, Fernanda, Schenker, Michael, Perfetti, Aldo, Lebbe, Celeste, Quéreux, Gaëlle, Meier, Friedegund, Curti, Brendan D, Rojas, Carlos, Arriaga, Yull, Yang, Haisu, Zhou, Ming, Ravimohan, Shruthi, Statkevich, Paul, Tagliaferri, Mary A, Khushalani, Nikhil I
Published in Journal of clinical oncology (20.10.2023)
Published in Journal of clinical oncology (20.10.2023)
Get full text
Journal Article
A phase II trial of palbociclib combined to letrozole after progression on second-line chemotherapy for women with ER/PR-positive high-grade serous or endometrioid ovarian, fallopian tube, or peritoneal cancer: LACOG 1018
Damian, Fernanda Bronzon, Melo, Andreia Cristina De, Zibetti Dal Molin, Graziela, Rodrigues, Angelica Nogueira, Calabrich, Aknar Freire de Carvalho, Werutsky, Gustavo, Filho, Elias Abdo, Rebelatto, Taiane Francieli, de Jesus, Rafaela Gomes, Jimenez, Mirela Foresti
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article